Dataset Open Access

Optimisation of HTT-HAP40 purification using heparin affinity chromatography - 2019/01/29

Harding, Rachel; Arrowsmith, Cheryl; Edwards, Aled

Project: Biophysical investigation of purified HTT protein samples

Experiment: Optimisation of HTT-HAP40 purification using heparin affinity chromatography

Date completed:­ 2019/01/29

Rationale: The current protocol for HTT and HTT-HAP40 purification I am using requires a long incubation of clarified cell lysate with FLAG resin. To potentially improve yields and sample quality, it would perhaps be beneficial to have a quick heparin resin purification step prior to FLAG binding which may also remove contaminating nucleic acid material. To test this hypothesis, small-scale purification of Q23 HTT-HAP40 samples in different buffer systems were conducted using heparin and FLAG affinity chromatography which showed the sample bound heparin resin – see https://zenodo.org/record/2553669. Now this need to be scaled up and tested more stringently. 

Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research. Dr. Harding's research is also supported with generous funding from the Huntington Society of Canada and the CHDI Foundation. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
121
50
views
downloads
All versions This version
Views 121121
Downloads 5050
Data volume 31.4 MB31.4 MB
Unique views 106106
Unique downloads 3737
More info on how stats are collected.
Indexed in
Publication date:
January 29, 2019
DOI:
10.5281/zenodo.2600366

Zenodo DOI Badge

DOI 

10.5281/zenodo.2600366

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.2600366.svg)](https://doi.org/10.5281/zenodo.2600366)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.2600366.svg
   :target: https://doi.org/10.5281/zenodo.2600366

HTML 

<a href="https://doi.org/10.5281/zenodo.2600366"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.2600366.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.2600366.svg

Target URL 

https://doi.org/10.5281/zenodo.2600366

Keyword(s):
Huntingtin HTT Huntington's Disease HD HAP40 Heparin
Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.2600366 Jan 29, 2019
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.2600365. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export